Abstract: The present disclosure provides a method for preventing and/or treating a damage to micro vascular integrity comprising administering to a subject, a composition comprising selected cannabinoid, thereby maintaining the microvascular integrity.
Type:
Application
Filed:
August 2, 2021
Publication date:
September 28, 2023
Applicant:
SCISPARC LTD.
Inventors:
Ascher SHMULEWITZ, Adi ZULOFF-SHANI, Ephraim BRENER
Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
Type:
Application
Filed:
September 29, 2022
Publication date:
February 9, 2023
Applicant:
SciSparc Ltd.
Inventors:
Ephraim BRENER, Elran HABER, Adi ZULOFF-SHANI, Ascher SHMULEWITZ
Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
Type:
Grant
Filed:
June 9, 2020
Date of Patent:
November 8, 2022
Assignee:
SciSparc Ltd.
Inventors:
Ephraim Brener, Elran Haber, Adi Zuloff-Shani, Ascher Shmulewitz
Abstract: The present disclosure provides pharmaceutical compositions and methods for treating paracetamol amenable conditions, such as pain and fever. The pharmaceutical compositions comprise certain combinations of derivatives of 4-Aminophenols and N-acylethanolamines. Also disclosed are methods and kits for treating or minimizing paracetamol amenable conditions.
Type:
Application
Filed:
April 22, 2020
Publication date:
July 7, 2022
Applicant:
SCISPARC LTD.
Inventors:
Ascher SHMULEWITZ, Adi ZULOFF-SHANI, Ephraim BRENER
Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.